Randomized Open-Label Trial to Evaluate the Effectiveness of Diet Management With a Losartan Titration Regimen Versus Losartan Titration Regimen Alone on Blood Pressure Reduction in Hypertensives.
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Losartan (Primary) ; Calcium channel antagonists; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms SAALT
- Sponsors Merck & Co
- 05 May 2010 Actual end date (1 Jan 2010) added as reported by ClinicalTrials.gov record.
- 05 May 2010 Actual patient number (974) added as reported by ClinicalTrials.gov.
- 05 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.